ICD10 code of Adult-onset Stills Disease and ICD9 code

Adult-onset Still's disease (AOSD) is classified under the ICD-10 code M06.1, which specifically denotes Adult-onset Still's disease. In the previous ICD-9-CM classification system, this condition was coded as 714.2, which categorized other specified rheumatoid arthritis.

What is Adult-onset Still's disease?

Adult-onset Still's disease is a rare, systemic inflammatory disorder characterized by the classic triad of high spiking fevers, a salmon-colored evanescent rash, and joint pain. Unlike typical rheumatoid arthritis, Adult-onset Still's disease is considered an autoinflammatory condition, meaning the body’s innate immune system triggers inflammation without the presence of autoantibodies. With 689 members currently sharing their experiences on DiseaseMaps.org, we recognize the significant impact this disease has on systemic health, including the potential for complications in the heart, lungs, and kidneys.

How is Adult-onset Still's disease diagnosed?

There is no single "gold standard" diagnostic test for Adult-onset Still's disease. Diagnosis is typically one of exclusion, meaning physicians must rule out infections, malignancies, and other autoimmune conditions. Rheumatologists frequently utilize the Yamaguchi criteria to aid in the diagnosis of Adult-onset Still's disease. Key clinical features identified by specialists include:

• Daily high spiking fevers (usually ≥39°C) lasting at least one week.


• Arthralgia or arthritis lasting for two weeks or more.


• A non-pruritic, salmon-pink macular or maculopapular rash.


• Leukocytosis (elevated white blood cell count), specifically with neutrophilia.


• Elevated serum ferritin levels, which are often significantly higher than in other inflammatory conditions.

What are the primary treatment approaches?

Management of Adult-onset Still's disease focuses on suppressing systemic inflammation and preventing long-term organ damage. Because this condition affects multiple body systems—including the circulatory, respiratory, and urinary systems—treatment is often aggressive. Patients are typically managed with a combination of high-dose corticosteroids, disease-modifying antirheumatic drugs (DMARDs) like methotrexate, and, in more refractory cases, biologic agents that target specific inflammatory cytokines such as IL-1 or IL-6. Vitamins may be suggested as supportive care, but they do not treat the underlying inflammatory mechanism of Adult-onset Still's disease.

How does this condition impact daily life?

Living with a chronic, multisystem condition like Adult-onset Still's disease requires significant emotional and physical adjustment. The unpredictability of "flares"—periods where symptoms like pleurisy, severe muscle pain, or spiking fevers return—can lead to isolation and anxiety. It is essential for patients to work closely with their rheumatology team to monitor for potential complications in the liver, heart, or kidneys, while also seeking psychological support to manage the burden of living with a rare, chronic illness.

Next steps

• Consult a board-certified rheumatologist to establish a long-term monitoring plan for systemic organ involvement.


• Track your daily symptoms, including fever patterns and rash appearance, to provide accurate data during clinical appointments.


• Join the Adult-onset Still's disease community on DiseaseMaps.org to connect with others sharing similar experiences and treatment journeys.


• Request a referral to a clinical psychologist or support group specializing in chronic, rare inflammatory diseases.

Medical disclaimer: This content is for informational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician with any questions regarding a medical condition.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Adult-onset Still's disease overview.


• Orphanet: Rare disease database entry for Adult-onset Still's disease (ORPHA:3249).


• OMIM (Online Mendelian Inheritance in Man): Clinical features and genetic associations of Still's disease.


• The American College of Rheumatology: Guidelines for the management of adult systemic inflammatory conditions.